Generics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
160
NCT03258671
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer
Phase: N/A
Role: Lead Sponsor
Start: Oct 1, 2017
Completion: Dec 30, 2020
Loading map...